Novel Macrocyclic LRRK2 Inhibitors for Treating Parkinson's Disease

被引：1
|
作者：
Sabnis, Ram W. [1 ]
机构：
[1] Smith Gambrell & Russell LLP, Atlanta, GA 30309 USA
来源：
ACS MEDICINAL CHEMISTRY LETTERS | 2022年
关键词：
D O I：
10.1021/acsmedchemlett.1c00687
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [41] Catalyzing a Cure: Discovery and development of LRRK2 inhibitors for the treatment of Parkinson's disease
    Baidya, Anurag T. K.
    Deshwal, Sonam
    Das, Bhanuranjan
    Mathew, Alen T.
    Devi, Bharti
    Sandhir, Rajat
    Kumar, Rajnish
    BIOORGANIC CHEMISTRY, 2024, 143
  • [42] Structural Insights and Development of LRRK2 Inhibitors for Parkinson's Disease in the Last Decade
    Thakur, Gunjan
    Kumar, Vikas
    Lee, Keun Woo
    Won, Chungkil
    GENES, 2022, 13 (08)
  • [43] Small Molecule Kinase Inhibitors for LRRK2 and Their Application to Parkinson's Disease Models
    Kramer, Thomas
    Lo Monte, Fabio
    Goering, Stefan
    Amombo, Ghislaine Marlyse Okala
    Schmidt, Boris
    ACS CHEMICAL NEUROSCIENCE, 2012, 3 (03): : 151 - 160
  • [44] Inhibitors of LRRK2 Kinase Activity To Probe the Treatment Option in Parkinson's Disease
    Rautio, Jarkko
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (22) : 9414 - 9415
  • [45] LRRK2 mutations in Parkinson disease
    Farrer, M
    Stone, J
    Mata, IF
    Lincoln, S
    Kachergus, J
    Hulihan, M
    Strain, KJ
    Maraganore, DM
    NEUROLOGY, 2005, 65 (05) : 738 - 740
  • [46] The structure of LRRK2 and the conformational changes that are associated with LRRK2 activation and Parkinson's disease pathogenesis
    Weng, Jui-Hung
    Auto, Philip
    Lu, Tsan-Wen
    Taylor, Susan
    FASEB JOURNAL, 2020, 34
  • [47] The Structure of LRRK2 and the Conformational Changes that are Associated with LRRK2 Activation and Parkinson's Disease Pathogenesis
    Weng, Jui-Hung
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 41A - 41A
  • [48] Presynaptic dysfunction in Parkinson's disease: a focus on LRRK2
    Belluzzi, Elisa
    Greggio, Elisa
    Piccoli, Giovanni
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2012, 40 : 1111 - 1116
  • [49] The Discovery of LRRK2 Mutations as a Cause of Parkinson's Disease
    Singleton, Andrew B.
    Gasser, Thomas
    MOVEMENT DISORDERS, 2020, 35 (04) : 551 - 554
  • [50] Genetics in Parkinson's disease -: the role of LRRK2 mutations
    Toft, M.
    ACTA NEUROLOGICA SCANDINAVICA, 2008, 117 (01): : 70 - 70
12345